Vimarsana
Biggest News Aggregation in the World

Page 6 - Mouse Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mouse Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mouse Models Today - Breaking & Trending Today

Modeling human diversity using diverse outbred mice - Vimarsana News

Modeling human diversity using diverse outbred mice

Find out how the Diversity Outbred mouse platform from The Jackson Laboratory is increasing studies' genetic diversity

NIH Renews Knockout Mouse Project for 3rd Time - Vimarsana News

NIH Renews Knockout Mouse Project for 3rd Time

The University of California, Davis, has been awarded just over $12 million from the National Institutes of Health under the third and final five-year phase of the Knockout Mouse Phenotyping Project, or KOMP2. UC Davis is the lead organization in a consortium involving a partnership with The Centre for Phenogenomics in Toronto.

UNO Professor Explores Connection Between 'Social Hyperthermia' and Autism Spectrum Disorder - Vimarsana News

UNO Professor Explores Connection Between 'Social Hyperthermia' and Autism Spectrum Disorder

University of New Orleans psychology professor Christopher Harshaw has been awarded a three-year grant to research the nature of social hyperthermia using mouse models of ASD.

Source: uno.edu
Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022 - Vimarsana News

Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta's

Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the - Vimarsana News

Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta’s internal development program portfolio for hepatitis B virus (HBV) and its...